Search

everythinglearnresearchcommunity

for

Search:↓

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Bullous pemphigoid can look like erythema multiforme, so awareness is needed for proper treatment.

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Low PON1 levels may indicate and predict the severity of hair loss.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

MCP@G improves diabetic wound healing by reducing stress and promoting tissue repair.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

Pentoxifylline effectively improves pretibial pruritic papular dermatitis.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Beta-HPV and MCPyV are linked to certain skin cancers, with ongoing research and vaccine development.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

MXD@CP could be a promising new topical treatment for hair loss.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

MMP-9 is essential for proper hair canal formation.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.